ACTAfroCentric Investment CorporationACT info
$0.16info1.79%24h
Global rank19800
Market cap$130.99M
Change 7d3.64%
YTD Performance1.42%
SP500 benchmarkUnderperform
P/E0
P/S0.26
Revenue$498.06M
Earnings$16.55M
Dividend yield-
Main Sector
Healthcare

AfroCentric Investment Corporation (ACT) Stock Overview

AfroCentric Investment Corporation Limited, an investment holding company, provides healthcare administration and health risk management solutions to the healthcare sector. The company operates through Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology segments. It engages in the retail and wholesale of pharmaceutical products under the Pharmacy Direct, Curasana Wholesaler, and Activo Health names. The company also offers HIV and other healthcare management solutions. It operates in South Africa, Botswana, Mauritius, Namibia, Eswatini, and Zimbabwe. The company was incorporated in 2008 and is based in Roodepoort, South Africa. AfroCentric Investment Corporation Limited operates as a subsidiary of Sanlam Limited.

ACT Stock Information

Symbol
ACT
Address
37 Conrad RoadRoodepoort, 1709South Africa
Founded
-
Trading hours
-
Website
https://www.afrocentric.za.com
Country
πŸ‡ΏπŸ‡¦ South Africa
Phone Number
27 11 671 2000

AfroCentric Investment Corporation (ACT) Price Chart

-
Value:-

AfroCentric Investment Corporation Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.16006514932393534
N/A
Market Cap
$130.99M
N/A
Shares Outstanding
818.36M
42.11%
Employees
5.50K
N/A
Shareholder Equity
3.50B
1.54%
Valuation
2023
Change
P/S Ratio
0.26
N/A
P/B Ratio
0.04
N/A
Growth
2023
Change
Return on Equity
0.0047
N/A
Earnings
2023
Change
Revenue
$498.06M
N/A
Earnings
$16.55M
N/A
Gross Margin
0.5228
N/A
Operating Margin
0.1945
N/A
Net income margin
0.0332
N/A
Financial Strength
2023
Change
Total Assets
$312.26M
N/A
Total Debt
$55.96M
N/A
Cash on Hand
$10.66M
N/A
Debt to Equity
0.0331
1.91%
Cash to Debt
0.1905
16.79%
Current Ratio
$1.27
-4.10%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
Β© 2024 Topstocks.org